Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.74 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.58 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.51 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.51 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.51 |
| ▸ | HNF4A | P41235 | 1/20 | 0.50 |
| ▸ | FNTA | P49354 | 1/20 | 0.48 |
| ▸ | FNTB | P49356 | 1/20 | 0.48 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23003 | 0.88 | TSHR (0.79) | TSHRCA1CA2CA9FOLH1 | |
| Ammonia Solution, Strong SCHEMBL27527756 | 0.86 | TSHR (0.76) | TSHRCA1CA2CA9FOLH1 | |
| SCHEMBL28370887 | 0.86 | TSHR (0.76) | TSHRCA1CA2CA9FOLH1 | |
| SCHEMBL11035548 | 0.86 | TSHR (0.60) | TSHRCA1CA2CA9KEAP1 | |
| SCHEMBL14408663 | 0.86 | HMGB1 (0.56) | TSHRCA1CA2CA9KEAP1 | |
| SCHEMBL69041 | 0.85 | TSHR (1.00) | TSHRCA1CA2CA9FOLH1 | |
| SCHEMBL7759867 | 0.85 | TSHR (0.74) | TSHRCA1CA2CA9FOLH1 | |
| SCHEMBL29580520 | 0.85 | TSHR (0.74) | TSHRCA1CA2CA9FOLH1 | |
| SCHEMBL11294507 | 0.84 | TSHR (0.54) | TSHRCA1CA2CA9KEAP1 | |
| SCHEMBL16950095 | 0.84 | TSHR (0.72) | TSHRCA1CA2CA9FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4725956-A1 | MODIFIED POLYPEPTIDE AND USE THEREOF IN FIELD OF ANALGESIA | Nanjing Anji Biotechnology Co., Ltd. (CN) | 2026-04-15 | — | — | EP | disclosed |
| EP-4617261-A1 | 2,4,5-TRISUBSTITUTED PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | Wenzhou Medical University (CN) | 2025-09-17 | — | — | EP | disclosed |
| EP-4371992-B1 | METHODS OF PREPARING GLUFOSINATE | YONGNONG BIOSCIENCES CO LTD (CN) | 2025-07-02 | — | — | EP | disclosed |
| WO-2025103336-A1 | USE OF TRIACETYL-3-HYDROXYPHENYLADENOSINE IN PREPARATION OF MOTION SIMULATION DRUG | 中国医学科学院药物研究所 | 2025-05-22 | — | — | WO | disclosed |
| US-12252501-B2 | Methods of preparing glufosinate | YONGNONG BIOSCIENCES CO., LTD. (CN) | 2025-03-18 | — | — | US | disclosed |
| WO-2025051160-A1 | 3CL PROTEASE INHIBITOR FOR TREATING OR PREVENTING CORONAVIRUS INFECTIONS AND USE THEREOF | 北京华益健康药物研究中心 | 2025-03-13 | — | — | WO | disclosed |
| WO-2025036296-A1 | JAK INHIBITOR COMPOUND AND USE THEREOF | 迈英诺医药科技（珠海）有限公司 | 2025-02-20 | — | — | WO | disclosed |
| WO-2025031396-A1 | SUBSTITUTED BENZOCYCLOBUTENE COMPOUND AND USES THEREOF IN THE FIELD OF MEDICINE | 杭州安道药业有限公司 | 2025-02-13 | — | — | WO | disclosed |
| WO-2025031498-A1 | TOLL-LIKE RECEPTOR AGONISTS AND USE THEREOF | 浙江海昶生物医药技术有限公司 | 2025-02-13 | — | — | WO | disclosed |
| WO-2025031393-A1 | SPIRO COMPOUND AND USE THEREOF IN THE FIELD OF MEDICINE | 杭州安道药业有限公司 | 2025-02-13 | — | — | WO | disclosed |
| EP-0410967-A1 | ZEOLITE COMPOSITIONS. | ETHYL CORP (US) | 1991-02-06 | — | — | EP | disclosed |
| US-4978651-A | With a colorless or light colored leuco dye for inducing color formation | RICOH COMPANY, LTD. (JP) | 1990-12-18 | — | — | US | disclosed |
| EP-0410967-A4 | ZEOLITE COMPOSITIONS. | ETHYL CORP (US) | 1990-12-03 | — | — | EP | disclosed |
| EP-0397375-A1 | Photosensitive composition and photosensitive lithographic printing plate | KONICA CORPORATION (JP) | 1990-11-14 | — | — | EP | disclosed |
| US-4917045-A | ADMINISTERING TO FERTILE EGG TO STIMULATE BONE GROWTH | ETHYL CORPORATION (US) | 1990-04-17 | — | — | US | disclosed |
| WO-1990000884-A1 | SILICON COMPOUNDS IN BONE TREATMENT | ETHYL CORPORATION (US) | 1990-02-08 | — | — | WO | disclosed |
| US-4870191-A | ASCORBIC ACID AND TETRAALKYL SILICATE; OSTEOPOROSIS | ETHYL CORPORATION (US) | 1989-09-26 | — | — | US | disclosed |
| WO-1989006965-A1 | ZEOLITE COMPOSITIONS | ETHYL CORPORATION (US) | 1989-08-10 | — | — | WO | disclosed |
| US-4611072-A | Heat-sensitive recording material | CIBA-GEIGY CORPORATION (US) | 1986-09-09 | — | — | US | disclosed |
| US-4536779-A | PHENOLSULFONYL SALT AS DEVELOPER FOR COLOR FORMER | CIBA-GEIGY CORPORATION (US) | 1985-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12252501-B2 | Methods of preparing glufosinate | GLUL, WRN, ASNS | TSHR 3632/4885CA1 2103/4885CA2 2106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.